Hooray for Apple! Apple Demands – er, Asks – That App Developers Provide Sources...
An iMedicalApps "exclusive" reports "information has now become available that suggests Apple is now looking to ensure the information contained in each medical app is appropriately validated" (see "Exclusive: Apple now...
Not Lost in Translation: Barcelona, Catalonia, and Global Pharmaguy
I recently attended the 3rd Annual Pharma eMarketing Congress hosted by Fleming Europe in Barcelona, Spain. While there, I managed to mix business, fun, and politics in the same trip.
This Congress...
Do You Trust This Man? Pfizer CEO Says Lack of Trust in Drug Industry...
He is Pfizer Chief Executive Officer Ian Read.
I wasn't one of the reporters "invited" to Pfizer headquarters in New York to listen to company leaders discuss improvements to research and development...
Is Social Media Effective for Pharma Marketing?
I am attending and presenting at the 3rd Annual Pharma eMarketing Congress in Barcelona (see here) this week. Yesterday, I attended the pre-conference Social Media Training Day workshop presented by Alexandra...
Just When You Thought Meta Tags Were Safe, Along Comes Twitter’s “Ad Card”
You might recall this post I made three years ago: "Who's in Charge of Your 'Invisible' Metadata? WARNING: Don't Invoke the 'Invisibility Rule'".
In that post I pointed out that Google automatically...
Is Your TweetChat “Regulation Safe?” Regulators Should Publish Opinions on Specific Social Media Initiatives...
Yesterday, I cited a bit of ABPI code of Practice in relation to Boehringer's #COPDChat: "Using twitter to alert health professionals about the publication of a study on a medicine is...
Will Social Media Make it Harder for Pharma to “Hide” Drug Side Effects?
John LaMattina, former Pfizer president of Research and Development, suggests that FDA regulations make it virtually impossible for the pharmaceutical industry to "hide" drug side effects. "Most people don’t have a...
Boehringer Takes My Advice and Will Host the First-Ever Disease Condition TweetChat: #COPDChat
Two-and-one-half years after AstraZeneca hosted the First-Ever pharma Twitter chat (see "OMG! AstraZeneca Hosts Twitter Chat & World Does NOT End!"), Boehringer Ingelheim (BI) has announced that it will host a...
Janssen Engages HIV Community on Tumblr: Build It and They Will Come?
A few months ago, I engaged Peter Houston (@Flipping_Pages) in a discussion about whether or not pharma "should" do Tumblr, a social media site that allows users to post text, photos,...
Boehringer Ingelheim’s Facebook Page Joins the “Over 50K Likes Club.” You’ve Come a Long...
Boehringer Ingelheim (BI) - the German pharma company with the famously difficult-for-nonGermans-to-pronounce name (see "BI's Famously Buxom and Unpronounceable YouTube Video") - just posted a video on YouTube expressing thanks for...
